diechop.pages.dev

When is the next taxotere bellwether trial


when is the next taxotere bellwether trial

Taxotere Lawsuit- Chemotherapy Drug | Permanent Hair Loss

Taxotere is a drug that is administered intravenously and it is intended to treat many different types of cancer. The drug works as a form of chemotherapy that is supposed to slow the cell growth of the cancerous tumor.  Over 15,000 lawsuits against Sanofi were filed asserting that the manufacturer neglected to properly warn physicians and patients concerning the potential of permanent hair loss, otherwise known as alopecia, which is widely known to be caused by Taxotere. As of  February 15th, 2022 there are 11,998 Taxotere hair loss lawsuits pending. Many victims are wondering about hair growth after taxotere.  Taxotere lawsuits filed in United States Federal Court have been consolidated in the Eastern District of Louisiana as multidistrict litigation (MDL). The Eastern District of Louisiana is located in New Orleans. The consolidated lawsuits have sustained some setbacks with a number of individual lawsuits dismissed. The manufacturer, Sanofi, has prevailed in the first two bellwether trials in the mdl.  The victims losing the first two bellwether trials is problematic for the long term sustainability of the Taxotere

Taxotere Lawsuits Overview & Updates

Recent studies have uncovered a concerning link between the chemotherapy drug Taxotere (docetaxel) and certain side effects related to the eyes and tear ducts.

These findings highlight the importance of understanding the potential risks associated with this medication, particularly for patients undergoing treatment for various types of breast cancer and lung cancer.

  • University of Texas, M.D. Anderson Cancer Center: Recognizes canalicular stenosis may be the underlying mechanism for epiphora in patients receiving weekly doses of the chemotherapy drug Taxotere.
  • Review of Ophthalmology: Researchers found that weekly administration of Taxotere is far more likely to lead to canalicular stenosis than administrating it every three weeks.
  • Kawasaki Medical School: Epiphora (excessive tearing) was reported to occur in up to 64% of breast cancer patients receiving docetaxel-based chemotherapy.

Healthcare providers should be aware of these side effects and consider alternative treatment options or dosing schedules when appropriate.

Further research is needed to develop strategies to mitigate these side effects and improve patient ou

Taxotere Hair and Vision Loss Lawsuit

This is the latest update on the Taxotere class action (MDL) lawsuits.

Where are we now in the Taxotere hair loss lawsuits?  There have been two bellwether trials.  One before the pandemic in 2019 and one last year.  Both have ended in a defeat for plaintiffs.

So things are not good with the Taxotere lawsuits at this stage.  Do some mass tort lawsuits often begin with losses and then the tide turns and plaintiffs start winning and the defendant offers fair settlement amounts?  Yes.  100%.  But let’s not pretend there are many silver linings when you lose two lawsuits in a row.

Some Good Taxotere News – Appellate Win

The first texture lawsuit to go to trial ended in a tough loss for the plaintiff.  But in a huge development, the 5th Circuit Court of Appeals ruled the plaintiff should receive a new trial because Sanofi offered inadmissible expert testimony at trial.  This is a big win that breathes new life into the Taxotere lawsuits.

Septemeber 2024 MDL Update

The plaintiffs in the MDL have filed a motion for reconsideration asking the MDL Judge to revisit her ruling earlier this year that requires a large group of individu

Taxotere Lawsuit Attorney in New York City

If you received Taxotere as part of your chemotherapy treatment for breast cancer and suffered permanent hair loss, you could be eligible for compensation. A lawsuit with help from the New York City Taxotere lawsuit attorneys at Sullivan Papain Block McManus Coffinas & Cannavo, PC could result in payment for your emotional distress and other damages. Call (212) 732-9000 today for a free consultation in New York.

Why Choose Us?

  • Our lawyers treat each product liability client with personal care and attention. We will treat your case as we would a family member’s.
  • Our firm has a long history of case success. We have secured over $2 billion in case results for past clients.
  • Our lawyers take cases on a contingency fee agreement. You will only pay for your attorney if he or she secures you financial compensation.

What Is Taxotere?

Taxotere is the brand name for the chemotherapy drug docetaxel. It works to prevent groups of cancerous cells from reproducing. Patients are injected with doses of Taxotere through a vein. Although it is a form of chemotherapy medication that is used to treat other types of cancers, it is especiall

Taxotere Vision Lawsuit

Our law firm is accepting new clients in all 50 states for a Taxotere eye injury class action lawsuit.

The breast cancer chemotherapy drug Taxotere is the subject of a new wave of product liability lawsuits by women alleging that the drug caused permanent vision damage. The lawsuits claim that the manufacturer of Taxotere, Sanofi, knew about the risk of permanent watery eyes from canalicular stenosis and deliberately failed to warn doctors or patients.

There are already 30,000 Taxotere lawsuits in a class action MDL alleging that the drug caused users to suffer permanent hair loss and that Sanofi failed to warn that this was a potential side effect. The new Taxotere watery eyes lawsuit differs from the Taxotere hair loss lawsuit and will be consolidated into a separate MDL (MDL 3023).

January 15, 2024 Update: There are now 258 pending cases in the Taxotere eye damage class action MDL. Only about 20 new cases have been added to this MDL since September.  This litigation is not moving quickly, that is for sure.

But the fact that the MDL is small is probably a blessing for victims. Why?

December 8, 2023 Update: There are currently 249 pending case